Skip to content

Michelle R Peace

3 papers in the library · 5 citations · publishing 2022-2024

Papers

Sort Most recent Most cited

Survey of U.S. Residents and Their Usage of Electronic Cigarettes with Drugs Other Than Nicotine.

Journal of Psychoactive Drugs 2024 Alaina K Holt, Alyssa K Rudy, Ashlee N Sawyer et al. 2 citations

Electronic cigarettes (e-cigs), originally intended to be used as cigarette substitutes, have evolved into discreet devices for consuming drugs other than nicotine (DOTNs). Presented are the results of an exploratory survey in which information regarding demographics, e-cig device type, DOTN use, frequency and context of use was collected. The average reported age of respondents was 27.4 years...

DOI: 10.1080/02791072.2023.2250353 (opens in new tab) Full text (opens in new tab) United states Substance use Vaping e-cigarettes Electronic cigarettes +5

Case report: Identification of AP-238 and 2-fluorodeschloroketamine in internet available powder samples sold as bucinnazine.

Forensic Science International July 1, 2023 Karissa N Resnik, Kala N Babb, Lori W Bekenstein et al. 2 citations

Novel synthetic opioids (NSOs) are a class of opioid agonists that include analogs of fentanyl and structurally distinct non-fentanyl compounds normally used as standalone products, heroin adulterants, or constituents of counterfeit pain pills. Most NSOs are not currently scheduled in the U.S., are predominantly illegally synthesized, and sold on the Darknet. Among them, the cinnamylpiperazine...

DOI: 10.1016/j.forsciint.2023.111732 (opens in new tab) Full text (opens in new tab) 2-fluoro-deschloroketamine Ap-238 Bucinnazine Dart-ms +3

Effects of acute Δ9 -tetrahydrocannabinol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice

Research Square December 29, 2022 Barkha J. Yadav-Samudrala, Ben L. Gorman, Hailey Dodson et al. 1 citation preprint

Abstract Cannabis use is highly prevalent especially among people living with HIV (PLWH). Activation of the anti-inflammatory and neuroprotective endocannabinoid system by phytocannabinoids, i.e. Δ9-tetrahydrocannabinol (THC), has been proposed to reduce HIV symptoms. However, THC’s effects on HIV-associated cognitive impairments are unclear. Using HIV-1 Tat transgenic mice, the current study...